These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 35661943)

  • 21. Hereditary diffuse gastric cancer: translation of CDH1 germline mutations into clinical practice.
    Guilford P; Humar B; Blair V
    Gastric Cancer; 2010 Mar; 13(1):1-10. PubMed ID: 20373070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and genomic characteristics of mucosal signet-ring cell carcinoma in Helicobacter pylori-uninfected stomach.
    Kiso M; Urabe Y; Ito M; Masuda K; Boda T; Kotachi T; Hata K; Yorita N; Nagasaki N; Abduwali M; Hiyama Y; Oka S; Tanaka S; Chayama K
    BMC Gastroenterol; 2020 Jul; 20(1):243. PubMed ID: 32727394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Germline mutation of the E-cadherin gene in three sibling cases with advanced gastric cancer: clinical consequences for the other family members.
    Mayrbaeurl B; Keller G; Schauer W; Burgstaller S; Czompo M; Hoebling W; Knoflach P; Duba HC; Hoefler H; Thaler J
    Eur J Gastroenterol Hepatol; 2010 Mar; 22(3):306-10. PubMed ID: 19474748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early-onset diffuse gastric cancer associated with a de novo large genomic deletion of CDH1 gene.
    Sugimoto S; Yamada H; Takahashi M; Morohoshi Y; Yamaguchi N; Tsunoda Y; Hayashi H; Sugimura H; Komatsu H
    Gastric Cancer; 2014 Oct; 17(4):745-9. PubMed ID: 23812922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Establishment and characterization of novel gastric signet-ring cell and non signet-ring cell poorly differentiated adenocarcinoma cell lines with low and high malignant potential.
    Murakami H; Nakanishi H; Tanaka H; Ito S; Misawa K; Ito Y; Ikehara Y; Kondo E; Kodera Y
    Gastric Cancer; 2013 Jan; 16(1):74-83. PubMed ID: 22450770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Colorectal signet ring cell carcinoma: Influence of EGFR, E-cadherin and MMP-13 expression on clinicopathological features and prognosis.
    Foda AAM; Aziz AA; Mohamed MA
    Ann Diagn Pathol; 2018 Feb; 32():41-46. PubMed ID: 29414397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Signet-ring cell carcinoma of the stomach: Impact on prognosis and specific therapeutic challenge.
    Pernot S; Voron T; Perkins G; Lagorce-Pages C; Berger A; Taieb J
    World J Gastroenterol; 2015 Oct; 21(40):11428-38. PubMed ID: 26523107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proteomic Profiling of Gastric Signet Ring Cell Carcinoma Tissues Reveals Characteristic Changes of the Complement Cascade Pathway.
    Fan Y; Bai B; Liang Y; Ren Y; Liu Y; Zhou F; Lou X; Zi J; Hou G; Chen F; Zhao Q; Liu S
    Mol Cell Proteomics; 2021; 20():100068. PubMed ID: 33676000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prophylactic Laparoscopic Total Gastrectomy with Jejunal Pouch Reconstruction in Patients Carrying a CDH1 Germline Mutation.
    Haverkamp L; van der Sluis PC; Ausems MG; van der Horst S; Siersema PD; Ruurda JP; Offerhaus GJ; van Hillegersberg R
    J Gastrointest Surg; 2015 Dec; 19(12):2120-5. PubMed ID: 26443527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CDH1 truncating mutations in the E-cadherin gene: an indication for total gastrectomy to treat hereditary diffuse gastric cancer.
    Norton JA; Ham CM; Van Dam J; Jeffrey RB; Longacre TA; Huntsman DG; Chun N; Kurian AW; Ford JM
    Ann Surg; 2007 Jun; 245(6):873-9. PubMed ID: 17522512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gastroscopic surveillance with targeted biopsies compared with random biopsies in CDH1 mutation carriers.
    van Dieren JM; Kodach LL; den Hartog P; van der Kolk LE; Sikorska K; van Velthuysen MF; van Sandick JW; Koemans WJ; Snaebjornsson P; Cats A
    Endoscopy; 2020 Oct; 52(10):839-846. PubMed ID: 32408363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intragenic deletion of CDH1 as the inactivating mechanism of the wild-type allele in an HDGC tumour.
    Oliveira C; de Bruin J; Nabais S; Ligtenberg M; Moutinho C; Nagengast FM; Seruca R; van Krieken H; Carneiro F
    Oncogene; 2004 Mar; 23(12):2236-40. PubMed ID: 14661064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Case n(o) 6: Signet ring cell intramucosal carcinoma in hereditary diffuse gastric cancer with mutated CDH1 gene].
    Svrcek M
    Ann Pathol; 2011 Oct; 31(5):381-4. PubMed ID: 21982246
    [No Abstract]   [Full Text] [Related]  

  • 34. Hereditary gastric cancer.
    Carneiro F
    Pathologe; 2012 Nov; 33 Suppl 2():231-4. PubMed ID: 23052347
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel mechanism of a CDH1 splicing mutation in a Korean patient with signet ring cell carcinoma.
    Kim S; Ki CS; Kim KM; Lee MG; Kim S; Bae JM; Kim JW
    BMB Rep; 2011 Nov; 44(11):725-9. PubMed ID: 22118538
    [TBL] [Abstract][Full Text] [Related]  

  • 36. No mucosal escape of signet-ring cell carcinoma for ten years in a patient with familial aggregation of gastric cancer.
    Tanis PJ; Ten Kate FJ; van Lanschot JJ
    J Surg Oncol; 2008 Mar; 97(3):294-6. PubMed ID: 18161866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A prospective study of total gastrectomy for CDH1-positive hereditary diffuse gastric cancer.
    Chen Y; Kingham K; Ford JM; Rosing J; Van Dam J; Jeffrey RB; Longacre TA; Chun N; Kurian A; Norton JA
    Ann Surg Oncol; 2011 Sep; 18(9):2594-8. PubMed ID: 21424370
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcriptomic profiling and quantitative high-throughput (qHTS) drug screening of CDH1 deficient hereditary diffuse gastric cancer (HDGC) cells identify treatment leads for familial gastric cancer.
    Chen I; Mathews-Greiner L; Li D; Abisoye-Ogunniyan A; Ray S; Bian Y; Shukla V; Zhang X; Guha R; Thomas C; Gryder B; Zacharia A; Beane JD; Ravichandran S; Ferrer M; Rudloff U
    J Transl Med; 2017 May; 15(1):92. PubMed ID: 28460635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intracellular MUC20 variant 2 maintains mitochondrial calcium homeostasis and enhances drug resistance in gastric cancer.
    Fu L; Yonemura A; Yasuda-Yoshihara N; Umemoto T; Zhang J; Yasuda T; Uchihara T; Akiyama T; Kitamura F; Yamashita K; Okamoto Y; Bu L; Wei F; Hu X; Liu Y; Ajani JA; Tan P; Baba H; Ishimoto T
    Gastric Cancer; 2022 May; 25(3):542-557. PubMed ID: 35166958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Indications for Total Gastrectomy in CDH1 Mutation Carriers and Outcomes of Risk-Reducing Minimally Invasive and Open Gastrectomies.
    Vos EL; Salo-Mullen EE; Tang LH; Schattner M; Yoon SS; Gerdes H; Markowitz AJ; Mandelker D; Janjigian Y; Offitt K; Coit DG; Stadler ZK; Strong VE
    JAMA Surg; 2020 Nov; 155(11):1050-1057. PubMed ID: 32997132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.